Activity of transaminases and gamma glutamyl transferase (γ-GT) in plasma but also markers of glucose and lipid metabolism as well as levels of C-reactive protein (CRP), plasminogen activator inhibitor 1 (PAI-1), uric acid, leptin and body mass index (BMI) as well as waist circumference were significantly higher in NAFLD patients than in controls. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.